Antiemetic effects of N-3389, a newly synthesized 5-HT 3 and 5-HT 4 receptor antagonist, in ferrets

By Minami M.   Endo T.   Tamakai H.   Ogawa T.   Hamaue N.   Hirafuji M.   Monma Y.   Yoshioka M.   Hagihara K.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite

A-315456: a selective 1D -adrenoceptor antagonist with minimal dopamine D 2 and 5-HT 1A receptor affinity

By Buckner S.A.   Milicic I.   Daza A.   Lynch J.J.   Kolasa T.   Nakane M.   Sullivan J.P.   Brioni J.D.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 123-127

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of HTR3C mutations for association with 5HT₃ receptor antagonist anti-emetic efficacy

By Ward Michael B   Kotasek Dusan   McKinnon Ross A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1027-1033

Future Medicine

Access to resources Recommend Favorite

Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

By Jaworski J.N.   Gonzales R.A.   Randall P.K.  

European Journal of Pharmacology, Vol. 418, Iss. 3, 2001-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite